• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人工智能与自然语言处理相结合,整合电子健康记录的结构化和自由文本数据,以识别非瓣膜性心房颤动,从而降低中风和死亡风险:评估和病例对照研究。

Using Artificial Intelligence With Natural Language Processing to Combine Electronic Health Record's Structured and Free Text Data to Identify Nonvalvular Atrial Fibrillation to Decrease Strokes and Death: Evaluation and Case-Control Study.

机构信息

Department of Biomedical Informatics, University at Buffalo, Buffalo, NY, United States.

Bioinformatics Laboratory, Department of Veterans Affairs, VA Western New York Healthcare System, Buffalo, NY, United States.

出版信息

J Med Internet Res. 2021 Nov 9;23(11):e28946. doi: 10.2196/28946.

DOI:10.2196/28946
PMID:34751659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8663460/
Abstract

BACKGROUND

Nonvalvular atrial fibrillation (NVAF) affects almost 6 million Americans and is a major contributor to stroke but is significantly undiagnosed and undertreated despite explicit guidelines for oral anticoagulation.

OBJECTIVE

The aim of this study is to investigate whether the use of semisupervised natural language processing (NLP) of electronic health record's (EHR) free-text information combined with structured EHR data improves NVAF discovery and treatment and perhaps offers a method to prevent thousands of deaths and save billions of dollars.

METHODS

We abstracted 96,681 participants from the University of Buffalo faculty practice's EHR. NLP was used to index the notes and compare the ability to identify NVAF, congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65 to 74 years, sex category (CHADS-VASc), and Hypertension, Abnormal liver/renal function, Stroke history, Bleeding history or predisposition, Labile INR, Elderly, Drug/alcohol usage (HAS-BLED) scores using unstructured data (International Classification of Diseases codes) versus structured and unstructured data from clinical notes. In addition, we analyzed data from 63,296,120 participants in the Optum and Truven databases to determine the NVAF frequency, rates of CHADS‑VASc ≥2, and no contraindications to oral anticoagulants, rates of stroke and death in the untreated population, and first year's costs after stroke.

RESULTS

The structured-plus-unstructured method would have identified 3,976,056 additional true NVAF cases (P<.001) and improved sensitivity for CHADS-VASc and HAS-BLED scores compared with the structured data alone (P=.002 and P<.001, respectively), causing a 32.1% improvement. For the United States, this method would prevent an estimated 176,537 strokes, save 10,575 lives, and save >US $13.5 billion.

CONCLUSIONS

Artificial intelligence-informed bio-surveillance combining NLP of free-text information with structured EHR data improves data completeness, prevents thousands of strokes, and saves lives and funds. This method is applicable to many disorders with profound public health consequences.

摘要

背景

非瓣膜性心房颤动(NVAF)影响近 600 万美国人,是中风的主要诱因,但尽管有明确的口服抗凝治疗指南,NVAF 的诊断和治疗仍严重不足。

目的

本研究旨在探讨是否使用电子病历(EHR)的半监督自然语言处理(NLP)对非结构化文本信息进行处理,并结合结构化 EHR 数据,提高 NVAF 的发现和治疗效果,或许可以提供一种预防数千人死亡和节省数十亿美元的方法。

方法

我们从布法罗大学教职员工的 EHR 中提取了 96681 名参与者。使用 NLP 对笔记进行索引,并比较使用非结构化数据(国际疾病分类代码)与使用临床笔记中的结构化和非结构化数据来识别 NVAF、充血性心力衰竭、高血压、年龄≥75 岁、糖尿病、中风或短暂性脑缺血发作、血管疾病、65 至 74 岁年龄组、性别类别(CHADS-VASc)和高血压、肝/肾功能异常、中风史、出血史或倾向、INR 不稳定、老年人、药物/酒精使用(HAS-BLED)评分的能力。此外,我们分析了 Optum 和 Truven 数据库中 63296120 名参与者的数据,以确定未经治疗人群中 NVAF 的频率、CHADS-VASc 评分≥2 的比率和无口服抗凝剂禁忌的比率、中风和死亡率,以及中风后第一年的费用。

结果

与仅使用结构化数据相比,结构化加非结构化方法将识别出 3976056 例额外的真正 NVAF 病例(P<.001),并提高 CHADS-VASc 和 HAS-BLED 评分的敏感性(分别为 P=.002 和 P<.001),敏感性提高 32.1%。对于美国来说,这种方法可以预防估计 176537 例中风,挽救 10575 条生命,并节省超过 135 亿美元。

结论

将 NLP 对非结构化文本信息的自然语言处理与结构化 EHR 数据相结合的人工智能辅助生物监测,可以提高数据的完整性,预防数千例中风,并拯救生命和资金。这种方法适用于许多具有深远公共卫生影响的疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd43/8663460/d380393a752c/jmir_v23i11e28946_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd43/8663460/d380393a752c/jmir_v23i11e28946_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd43/8663460/d380393a752c/jmir_v23i11e28946_fig1.jpg

相似文献

1
Using Artificial Intelligence With Natural Language Processing to Combine Electronic Health Record's Structured and Free Text Data to Identify Nonvalvular Atrial Fibrillation to Decrease Strokes and Death: Evaluation and Case-Control Study.利用人工智能与自然语言处理相结合,整合电子健康记录的结构化和自由文本数据,以识别非瓣膜性心房颤动,从而降低中风和死亡风险:评估和病例对照研究。
J Med Internet Res. 2021 Nov 9;23(11):e28946. doi: 10.2196/28946.
2
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中,HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.
3
Comparison of the CHADS-VASc, CHADS, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.CHADS-VASc、CHADS、HAS-BLED、ORBIT和ATRIA风险评分在预测心房颤动患者非维生素K拮抗剂口服抗凝药相关出血中的比较
Am J Cardiol. 2017 Nov 1;120(9):1549-1556. doi: 10.1016/j.amjcard.2017.07.051. Epub 2017 Jul 31.
4
Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.心房颤动真实世界患者的卒中与出血风险共分布:欧洲心脏调查
Am J Med. 2014 Oct;127(10):979-986.e2. doi: 10.1016/j.amjmed.2014.05.003. Epub 2014 May 13.
5
Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.抗血小板治疗与华法林联用的亚最佳抗凝治疗对非瓣膜性心房颤动患者临床结局的影响:一项全人群队列研究。
Heart Rhythm. 2016 Aug;13(8):1581-8. doi: 10.1016/j.hrthm.2016.03.049. Epub 2016 Mar 28.
6
Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.非瓣膜性心房颤动患者接受口服抗凝剂治疗的风险水平和不良临床结局。
JAMA Netw Open. 2022 Aug 1;5(8):e2229333. doi: 10.1001/jamanetworkopen.2022.29333.
7
CHADS-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban.接受利伐沙班治疗的非瓣膜性心房颤动患者的CHADS-VASc评分与严重出血
Ann Emerg Med. 2017 May;69(5):541-550.e1. doi: 10.1016/j.annemergmed.2016.09.032. Epub 2016 Nov 29.
8
Reviewing a clinical decision aid for the selection of anticoagulation treatment in patients with nonvalvular atrial fibrillation: applications in a US managed care health plan database.评估一种用于非瓣膜性心房颤动患者抗凝治疗选择的临床决策辅助工具:在美国管理式医疗健康计划数据库中的应用
Clin Ther. 2014 Nov 1;36(11):1566-1573.e3. doi: 10.1016/j.clinthera.2014.09.016. Epub 2014 Oct 23.
9
Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs.在参加 Medicare 和 Veterans Affairs 的非瓣膜性心房颤动肥胖患者中,阿哌沙班与华法林的有效性和安全性。
Am J Cardiol. 2022 Jan 15;163:43-49. doi: 10.1016/j.amjcard.2021.09.047.
10
Comparison of HAS-BLED and HAS-BED Versus CHADS and CHADSVASC Stroke and Bleeding Scores in Patients With Atrial Fibrillation.心房颤动患者中HAS - BLED和HAS - BED与CHADS和CHADSVASC卒中及出血评分的比较
Am J Cardiol. 2017 Apr 1;119(7):1012-1016. doi: 10.1016/j.amjcard.2016.12.007. Epub 2017 Jan 26.

引用本文的文献

1
Trends in electronic health record metadata use for management purposes.用于管理目的的电子健康记录元数据使用趋势。
Learn Health Syst. 2025 Feb 13;9(3):e70001. doi: 10.1002/lrh2.70001. eCollection 2025 Jul.
2
Semantic Clinical Artificial Intelligence vs Native Large Language Model Performance on the USMLE.语义临床人工智能与原生大语言模型在美国医师执照考试中的表现对比
JAMA Netw Open. 2025 Apr 1;8(4):e256359. doi: 10.1001/jamanetworkopen.2025.6359.
3
Improving Phenotyping of Patients With Immune-Mediated Inflammatory Diseases Through Automated Processing of Discharge Summaries: Multicenter Cohort Study.

本文引用的文献

1
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.2019年美国心脏协会/美国心脏病学会/心律学会对2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南的聚焦更新:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会与胸外科医师协会合作报告
Circulation. 2019 Jul 9;140(2):e125-e151. doi: 10.1161/CIR.0000000000000665. Epub 2019 Jan 28.
2
Healthcare impact of personalized medicine using genetic testing: an exploratory analysis for warfarin.使用基因检测的个性化医疗对医疗保健的影响:对华法林的探索性分析。
Per Med. 2008 May;5(3):279-284. doi: 10.2217/17410541.5.3.279.
3
通过出院小结自动处理改善免疫介导性炎症疾病患者的表型分析:多中心队列研究
JMIR Med Inform. 2025 Apr 9;13:e68704. doi: 10.2196/68704.
4
Data science and artificial intelligence in biology, health, and healthcare.生物学、健康与医疗保健领域的数据科学与人工智能
J Clin Transl Sci. 2025 Feb 14;9(1):e56. doi: 10.1017/cts.2025.28. eCollection 2025.
5
Improving Clinical Documentation with Artificial Intelligence: A Systematic Review.利用人工智能改善临床文档记录:一项系统综述。
Perspect Health Inf Manag. 2024 Jun 1;21(2):1d. eCollection 2024 Summer-Fall.
6
Stroke Diagnosis and Prediction Tool Using ChatGLM: Development and Validation Study.使用ChatGLM的中风诊断与预测工具:开发与验证研究
J Med Internet Res. 2025 Feb 26;27:e67010. doi: 10.2196/67010.
7
The Sociodemographic Biases in Machine Learning Algorithms: A Biomedical Informatics Perspective.机器学习算法中的社会人口统计学偏差:生物医学信息学视角
Life (Basel). 2024 May 21;14(6):652. doi: 10.3390/life14060652.
8
AI Quality Standards in Health Care: Rapid Umbrella Review.医疗保健中的人工智能质量标准:快速伞式综述。
J Med Internet Res. 2024 May 22;26:e54705. doi: 10.2196/54705.
9
[Artificial intelligence in wearable electrocardiogram monitoring].[可穿戴心电图监测中的人工智能]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023 Dec 25;40(6):1084-1092. doi: 10.7507/1001-5515.202301032.
10
Applications of the Natural Language Processing Tool ChatGPT in Clinical Practice: Comparative Study and Augmented Systematic Review.自然语言处理工具ChatGPT在临床实践中的应用:比较研究与增强型系统评价
JMIR Med Inform. 2023 Nov 28;11:e48933. doi: 10.2196/48933.
Bedside Computer Vision - Moving Artificial Intelligence from Driver Assistance to Patient Safety.床边计算机视觉——将人工智能从驾驶辅助应用于患者安全
N Engl J Med. 2018 Apr 5;378(14):1271-1273. doi: 10.1056/NEJMp1716891.
4
Socioeconomic disparities in first stroke incidence, quality of care, and survival: a nationwide registry-based cohort study of 44 million adults in England.社会经济差异对首次脑卒中发病、医疗质量和生存的影响:一项基于全国登记的队列研究,纳入了英格兰 4400 万成年人。
Lancet Public Health. 2018 Apr;3(4):e185-e193. doi: 10.1016/S2468-2667(18)30030-6. Epub 2018 Mar 15.
5
All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin.全因、卒中和出血特异性医疗保健费用:新型抗凝药物达比加群酯或华法林治疗的非瓣膜性心房颤动(NVAF)患者的比较。
Am J Cardiovasc Drugs. 2017 Dec;17(6):481-492. doi: 10.1007/s40256-017-0244-1.
6
HTP-NLP: A New NLP System for High Throughput Phenotyping.HTP-NLP:一种用于高通量表型分析的新型自然语言处理系统。
Stud Health Technol Inform. 2017;235:276-280.
7
Automating Clinical Score Calculation within the Electronic Health Record. A Feasibility Assessment.电子健康记录中临床评分计算的自动化。可行性评估。
Appl Clin Inform. 2017 Apr 12;8(2):369-380. doi: 10.4338/ACI-2016-09-RA-0149.
8
Utilization of Positive and Negative Controls to Examine Comorbid Associations in Observational Database Studies.在观察性数据库研究中利用阳性和阴性对照来检验共病关联
Med Care. 2017 Mar;55(3):244-251. doi: 10.1097/MLR.0000000000000640.
9
Stroke prevention in atrial fibrillation.心房颤动的卒中预防。
Lancet. 2016 Aug 20;388(10046):806-17. doi: 10.1016/S0140-6736(16)31257-0.
10
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.达比加群、利伐沙班和阿哌沙班与华法林相比治疗非瓣膜性心房颤动的有效性和安全性。
J Am Heart Assoc. 2016 Jun 13;5(6):e003725. doi: 10.1161/JAHA.116.003725.